Cashu
Omeros Gears Up for Earnings Report Amid Pipeline Developments and Market Anticipation
3 days ago
Stocks
Health Care
omer
Omeros
NASDAQ: OMER
+1.60 (+25.48%)
7.88
USD
At close at Nov 14, 21:38 UTC
Overview
Loading chart...
Key Stats
Market Cap
535.60M
Dividend Yield
0.00%
P/E Ratio
-4.42
EPS
-2.71
Revenue
-
Avg. Volume
2.07M
About
What does OMER do?
Omeros, a Seattle-based biopharmaceutical company with 198 employees, focuses on developing therapeutics for immunologic disorders and is advancing several candidates, including narsoplimab and OMS527, in clinical trials. The company went public on October 8, 2009.
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.